Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-23-018508

Options or other derivatives

  • Chief Commercial Officer acquired 90,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Von Seggern Christopher · Chief Commercial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-10 Grant or award : show line 1 in the form Stock Option (Right to Buy) +90,000 90,000 D
Loading xslF345X03/doc4.xml…